DenervationMuscle DenervationAutonomic DenervationSympathectomyClinical Trials as TopicParasympathectomySympathetic Nervous SystemSympathectomy, ChemicalMuscular AtrophyGanglionectomyTime FactorsMusclesClinical Trials, Phase III as TopicPressoreceptorsDouble-Blind MethodTreatment OutcomeMuscle, SkeletalBlood PressureResearch DesignNeuromuscular JunctionClinical Trials, Phase II as TopicVagotomyNerve RegenerationClinical Trials, Phase I as TopicCarotid SinusControlled Clinical Trials as TopicKidneyVagus NerveCranial Nerve DiseasesNorepinephrineReceptors, CholinergicSciatic Nerve3-IodobenzylguanidineOxidopamineAutonomic Nervous System DiseasesParasympathetic Nervous SystemReflexCarotid BodyDogsDiaphragmFollow-Up StudiesRats, Inbred StrainsNeurons, EfferentRats, Sprague-DawleyHeart RateProspective StudiesPlacebosRats, WistarElectromyographyGlossopharyngeal NerveAdrenergic FibersMotor NeuronsElectric StimulationHindlimbHeartMuscle ContractionHydroxydopaminesHypertensionClinical ProtocolsPatient SelectionChemoreceptor CellsEarly Termination of Clinical TrialsMuscle ProteinsSingle-Blind MethodMotor EndplateBaroreflexMulticenter Studies as TopicNatriuresisEdrophoniumMuscle Fibers, SkeletalClinical Trials Data Monitoring CommitteesMuscle Fibers, Fast-TwitchCatsSympatholyticsEphedrineTyramineDiuresisShy-Drager SyndromeHyperhidrosisTrigeminal NerveCapsaicinRenal ArteryDose-Response Relationship, DrugDrug Administration ScheduleSinus of ValsalvaHypoglossal NerveAtrophySodium CyanideAutonomic Fibers, PreganglionicStellate GanglionAutonomic Fibers, PostganglionicNerve DegenerationPrimary DysautonomiasPure Autonomic FailureCatecholaminesTongueAxonsPeripheral NervesMyogeninGanglia, Sympathetic